Breaking News Instant updates and real-time market news.

BIIB

Biogen

$319.35

-2.82 (-0.88%)

04:55
12/04/17
12/04
04:55
12/04/17
04:55

Biogen management to meet with RBC Capital

Meeting to be held in New York on December 4 hosted by RBC Capital.

  • 04

    Dec

BIIB Biogen
$319.35

-2.82 (-0.88%)

11/27/17
PIPR
11/27/17
NO CHANGE
PIPR
Overweight
Piper says Biogen strengthens MS franchise with 'reasonable' Alkermes deal
Piper Jaffray analyst Christopher Raymond said he sees the terms of Biogen's (BIIB) license and collaboration agreement to develop and commercialize Alkermes' (ALKS) ALKS 8700 as "reasonable" and he thinks the decision to in-license the drug makes sense and strengthens the Tecfidera franchise. Raymond maintains an Overweight rating on Biogen shares.
11/27/17
JEFF
11/27/17
NO CHANGE
Target $66
JEFF
Buy
Alkermes made prudent move selling ALKS 8700 rights, says Jefferies
Jefferies analyst Biren Amin thinks Alkermes (ALKS) made a prudent move by selling the rights of ALKS 8700 to Biogen (BIIB). The multiple sclerosis drug did not fit into the company's portfolio, Amin tells investors in an intraday research note. He believes Alkermes can now focus on programs such as ALKS-4230, an IL-2 for oncology. The analyst has a Buy rating on the shares with a $66 price target.
11/28/17
FBCO
11/28/17
NO CHANGE
Target $66
FBCO
Outperform
Alkermes agreement with Biogen should help monetize ALKS 8700, says Credit Suisse
Credit Suisse analyst Vamil Divan views Alkermes (ALKS) ALKS 8700 agreement with Biogen (BIIB) as a positive financial move for an underappreciated pipeline asset. The analyst notes that ALKS 8700 has not been given much credit by investors to date due to limited clinical data and patent uncertainty. Divan reiterates an Outperform rating and $66 price target on Alkermes shares.
11/28/17
BERN
11/28/17
NO CHANGE
Target $318
BERN
Outperform
Biogen price target raised to $318 from $310 at Bernstein
Bernstein analyst Aaron Gal raised his price target for Biogen (BIIB) to $318 from $310 after the company announced a licensing agreement with Alkermes (ALKS) to develop and commercialize ALKS 8700, a modified fumarate with a potentially differentiated GI tolerability profile. The analyst views this important improvement in Biogen's position in MS given the risk of generic Tecfidera. Further, Gal thinks the Street may be underappreciating the value of the asset. He reiterates an Outperform rating on Biogen's shares.

TODAY'S FREE FLY STORIES

XLE

Energy Select Sector SPDR

$69.49

-0.1 (-0.14%)

08:20
12/14/17
12/14
08:20
12/14/17
08:20
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$97.58

0.08 (0.08%)

08:20
12/14/17
12/14
08:20
12/14/17
08:20
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$15.70

-0.82 (-4.96%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Hot Stocks
Breaking Hot Stocks news story on Teva »

Teva says plans to pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

FB

Facebook

$178.30

1.34 (0.76%)

, GOOG

Alphabet

$1,040.61

0.13 (0.01%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Periodicals
MP criticizes Facebook after claims Russia spent just $1 on brexit ads, BI says »

Facebook (FB) has claimed…

FB

Facebook

$178.30

1.34 (0.76%)

GOOG

Alphabet

$1,040.61

0.13 (0.01%)

GOOGL

Alphabet Class A

$1,051.39

2.62 (0.25%)

TWTR

Twitter

$21.66

0.01 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

  • 07

    Feb

  • 18

    Mar

XLB

S&P Select Materials SPDR

$59.68

0.16 (0.27%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIOD

Diodes

$27.25

-0.32 (-1.16%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Upgrade
Diodes rating change  »

Diodes upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

XLU

Utilities SPDR

$55.40

0.15 (0.27%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$107.61

0.18 (0.17%)

, FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Periodicals
Disney to pay $2.5B break up fee if 21st Century Fox deal stopped by regulators 

Reported by CNBC.

DIS

Disney

$107.61

0.18 (0.17%)

FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

XLP

Consumer Staples Sector SPDR

$56.91

0.32 (0.57%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$83.98

0.29 (0.35%)

08:18
12/14/17
12/14
08:18
12/14/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$151.78

0.9 (0.60%)

08:18
12/14/17
12/14
08:18
12/14/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$246.30

0.86 (0.35%)

08:18
12/14/17
12/14
08:18
12/14/17
08:18
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMC

Vulcan Materials

$123.11

1.6 (1.32%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Recommendations
Vulcan Materials analyst commentary  »

Vulcan Materials backlog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$266.75

-0.03 (-0.01%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$107.61

0.18 (0.17%)

, FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Hot Stocks
Breaking Hot Stocks news story on Disney, 21st Century Fox, 21st Century Fox »

Disney expects 21st…

DIS

Disney

$107.61

0.18 (0.17%)

FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

LUV

Southwest

$63.14

-0.29 (-0.46%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Upgrade
Southwest rating change  »

Southwest upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

XLF

Financial Select Sector

$27.87

-0.35 (-1.24%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$37.34

-0.21 (-0.56%)

, PF

Pinnacle Foods

$56.21

-0.49 (-0.86%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Upgrade
Conagra Brands, Pinnacle Foods rating change  »

Conagra Brands upgraded…

CAG

Conagra Brands

$37.34

-0.21 (-0.56%)

PF

Pinnacle Foods

$56.21

-0.49 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

SMH

Market Vectors Semiconductor

$97.69

0.06 (0.06%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

PowerShares QQQ Trust

$155.99

0.3 (0.19%)

08:16
12/14/17
12/14
08:16
12/14/17
08:16
Technical Analysis
PowerShares QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOCA

Tocagen

$11.00

0.23 (2.14%)

, NBI

Nasdaq Biotechnology Index

$3,353.28

31.77279 (0.96%)

08:16
12/14/17
12/14
08:16
12/14/17
08:16
Hot Stocks
Tocagen added to Nasdaq Biotechnology Index »

Tocagen (TOCA) has been…

TOCA

Tocagen

$11.00

0.23 (2.14%)

NBI

Nasdaq Biotechnology Index

$3,353.28

31.77279 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

08:16
12/14/17
12/14
08:16
12/14/17
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$6,394.67

11.01433 (0.17%)

08:16
12/14/17
12/14
08:16
12/14/17
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$65.75

-0.2 (-0.30%)

, DIS

Disney

$107.61

0.18 (0.17%)

08:15
12/14/17
12/14
08:15
12/14/17
08:15
Recommendations
Pinnacle Financial, Disney, J.M. Smucker, NextEra Energy, Zoetis, Leggett & Platt, South Jersey Industries, Tanger Factory, Physicians Realty Trust, VMware, AT&T, American Water analyst commentary  »

Hilliard Lyons Top Ideas…

PNFP

Pinnacle Financial

$65.75

-0.2 (-0.30%)

DIS

Disney

$107.61

0.18 (0.17%)

SJM

J.M. Smucker

$118.15

0.2 (0.17%)

NEE

NextEra Energy

$156.47

-0.6 (-0.38%)

ZTS

Zoetis

$72.38

0.15 (0.21%)

LEG

Leggett & Platt

$45.92

-0.05 (-0.11%)

SJI

South Jersey Industries

$32.17

0.03 (0.09%)

SKT

Tanger Factory

$25.85

0.32 (1.25%)

DOC

Physicians Realty Trust

$18.46

0.35 (1.93%)

VMW

VMware

$121.87

1.83 (1.52%)

T

AT&T

$38.04

-0.06 (-0.16%)

AWK

American Water

$89.93

0.61 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 17

    Jan

08:15
12/14/17
12/14
08:15
12/14/17
08:15
General news
Jobless Claims to be reported at 08:30 »

Week of 12/9 Jobless…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.